HEPA — Hepion Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $0.80m
- $0.39m
- 17
- 52
- 21
- 19
Annual cashflow statement for Hepion Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.4 | -32.7 | -42.2 | -48.9 | -13.2 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.53 | 6.98 | 4.01 | 5.41 | -2.37 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.63 | -5.57 | 3.15 | 2.97 | -2.68 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -16.2 | -31.2 | -35 | -40.9 | -18.2 |
| Capital Expenditures | -0.088 | -0.13 | -0.016 | -0.014 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.002 | 0 | 0.002 | 0 | -0.6 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.086 | -0.13 | -0.014 | -0.014 | -0.6 |
| Financing Cash Flow Items | — | — | -2 | 0 | 1.85 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 43.1 | 82 | -5.14 | 4.49 | 4.35 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26.8 | 50.6 | -40.2 | -36.4 | -14.4 |